Transgender Persons: Clinical Trials

3 trials for Transgender Persons, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Recruiting 1

Follow Transgender Persons: new trials by email Literature Review of Transgender Persons trials Research Report on Transgender Persons

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons
Serogroup B meningococal vaccine - Meningococcal Meningitis, Serogroup B, Transgender Persons
Phase 4RecruitingUniversity Ghent2502025-01-312026-01-20
Effect of Estrogen Treatment on Drug Metabolism and Transport
Midazolam oral solution, Digoxin Oral Tablet, Acetaminophen Oral Tablet - Transgender Persons
Phase 4CompletedUniversity of Washington222022-11-012026-01-09
The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community
Emtricitabine / Tenofovir Disoproxil Oral Tablet, PrEP support - Transgender Persons, Pre-Exposure Prophylaxis
Phase 4CompletedPublic Health Foundation Enterprises, Inc.1582017-08-082021-04-21

Narrower conditions

Coitus (1)  ·  Meningitis, Meningococcal (1)

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Behavior (1)  ·  Central Nervous System Bacterial Infections (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Infections (1)  ·  Meningitis (1)  ·  Meningitis, Bacterial (1)  ·  Meningococcal Infections (1)  ·  Neisseriaceae Infections (1)  ·  Nervous System Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  Sexual Behavior (1)

Interventions

4CMenB vaccine (1)  ·  Acetaminophen (1)  ·  Digoxin (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Midazolam (1)

Sponsors

Public Health Foundation Enterprises, Inc. (1)  ·  University Ghent (1)  ·  University of Washington (1)

Countries

United States (2)  ·  Belgium (1)

Top investigators

Albert Y Liu, MD, MPH (1)  ·  Erin Wilson, DrPH (1)  ·  Prof. Dr. Isabel Leroux-Roels, PhD, MD (1)

NIH funding

K23GM147350 (1)